{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:25:14Z","timestamp":1790231114753,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["- 2020R1A2C201215513"],"award-info":[{"award-number":["- 2020R1A2C201215513"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A2C201215513"],"award-info":[{"award-number":["NRF-2020R1A2C201215513"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.arr.2022.101764","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T13:10:24Z","timestamp":1666271424000},"page":"101764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"82","author":[{"given":"Irin Sultana","family":"Nila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewan Md.","family":"Sumsuzzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ho","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashura Suleiman","family":"Kazema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggeun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2022.101764_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105185","article-title":"Oligomeric \u03b1-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease","volume":"148","author":"Agliardi","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2022.101764_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2022","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10571-019-00751-y","article-title":"Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases","volume":"40","author":"Barbagallo","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2022.101764_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mds.26544","article-title":"Diagnosis of Parkinson's disease: imaging and genetics","volume":"31","author":"Berg","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2022.101764_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson's disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2022.101764_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101764_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","article-title":"\u03b1-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson\u2019s disease","volume":"696","author":"Cao","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101764_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fncel.2018.00125","article-title":"The exosomal\/total \u03b1-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients","volume":"12","author":"Cerri","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/cells10030604","article-title":"Cytokine profile in plasma extracellular vesicles of parkinson\u2019s disease and the association with cognitive function","volume":"10","author":"Chan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arr.2022.101764_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/diagnostics10090684","article-title":"Plasma exosomal brain-derived neurotrophic factor correlated with the postural instability and gait disturbance\u2013Related motor symptoms in patients with Parkinson\u2019s disease","volume":"10","author":"Chung","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.arr.2022.101764_bib11","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100787R","article-title":"Plasma extracellular vesicles Tau and \u03b2\u2010amyloid as biomarkers of cognitive dysfunction of Parkinson's disease","volume":"35","author":"Chung","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2022.101764_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/biom11050744","article-title":"Plasma extracellular vesicle \u03b1-synuclein level in patients with parkinson\u2019s disease","volume":"11","author":"Chung","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2022.101764_bib13","article-title":"Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses","volume":"88","author":"Coughlan","year":"2020","journal-title":"Curr. Protoc. Cell. Biol."},{"key":"10.1016\/j.arr.2022.101764_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-7-42","article-title":"Exosomal cell-to-cell transmission of alpha synuclein oligomers","volume":"7","author":"Danzer","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2022.101764_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.arr.2022.101764_bib16","first-page":"S3","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2022.101764_bib17","doi-asserted-by":"crossref","first-page":"17455","DOI":"10.18632\/oncotarget.24736","article-title":"miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson\u2019s disease","volume":"9","author":"Dos Santos","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2022.101764_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.arr.2022.101764_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","article-title":"\u03b1-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy","volume":"142","author":"Dutta","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101764_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br. Med. J."},{"key":"10.1016\/j.arr.2022.101764_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5561690","article-title":"The behavior of patients with obsessive-compulsive disorder in dental clinics","volume":"2021","author":"Elkamash","year":"2021","journal-title":"Int. J. Dent."},{"key":"10.1016\/j.arr.2022.101764_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fncel.2019.00058","article-title":"Long non-coding RNAs associated with neurodegeneration-linked genes are reduced in Parkinson\u2019s disease patients","volume":"13","author":"Elkouris","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib23","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.mcn.2005.12.003","article-title":"Exosomes are released by cultured cortical neurones","volume":"31","author":"Faur\u00e9","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1212\/WNL.0000000000002436","article-title":"Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers","volume":"86","author":"Fraser","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101764_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mds.26686","article-title":"Ser (P)\u20101292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease","volume":"31","author":"Fraser","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2022.101764_bib27","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jclinepi.2010.09.016","article-title":"Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods","volume":"64","author":"Friedrich","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.arr.2022.101764_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.702639","article-title":"Alpha-synuclein as a biomarker of Parkinson\u2019s disease: good, but not good enough","volume":"13","author":"Ganguly","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1515\/CCLM.2001.047","article-title":"Parkinson\u2019s disease and other \u03b1-synucleinopathies","volume":"39","author":"Goedert","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.arr.2022.101764_bib30","article-title":"L1CAM\u2010associated extracellular vesicles: a systematic review of nomenclature, sources, separation, and characterization","volume":"1","author":"Gomes","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.arr.2022.101764_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson\u2019s disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2022.101764_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3892\/ijmm.2020.4806","article-title":"MicroRNA\u201134a\u20115p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: an exploratory study","volume":"47","author":"Grossi","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.arr.2022.101764_bib33","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2022.101764_bib34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00109-019-01810-z","article-title":"Exosomes from patients with Parkinson\u2019s disease are pathological in mice","volume":"97","author":"Han","year":"2019","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.arr.2022.101764_bib35","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e300","article-title":"Psychiatric manifestation in patients with Parkinson's disease","volume":"33","author":"Han","year":"2018","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.arr.2022.101764_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-021-00249-y","article-title":"Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson\u2019s disease","volume":"10","author":"He","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2022.101764_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","article-title":"Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls","volume":"11","author":"Heidarzadeh","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.arr.2022.101764_bib38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/nu11040708","article-title":"Vitamin C can shorten the length of stay in the ICU: a meta-analysis","volume":"11","author":"Hemil\u00e4","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2022.101764_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/704678","article-title":"Increased DJ-1 in urine exosome of Korean males with Parkinson\u2019s disease","volume":"2014","author":"Ho","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.arr.2022.101764_bib40","doi-asserted-by":"crossref","first-page":"e2332","DOI":"10.1212\/WNL.0000000000011853","article-title":"Development of a sensitive diagnostic assay for parkinson disease quantifying \u03b1-synuclein\u2013containing extracellular vesicles","volume":"96","author":"Hong","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101764_bib41","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1021\/acsbiomaterials.1c00217","article-title":"Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications","volume":"7","author":"Huda","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.arr.2022.101764_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.738442","article-title":"The emerging role of neural cell-derived exosomes in intercellular communication in health and neurodegenerative diseases","volume":"15","author":"Huo","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib43","series-title":"Joanna Briggs Institute Reviewers' Manual","article-title":"JBI critical appraisal checklist for case control studies","author":"Institute","year":"2016"},{"key":"10.1016\/j.arr.2022.101764_bib44","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib45","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bbamem.2016.02.011","article-title":"Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases","volume":"1858","author":"Janas","year":"2016","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.arr.2022.101764_bib46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","article-title":"Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism","volume":"91","author":"Jiang","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2022.101764_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017478","article-title":"Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.arr.2022.101764_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101593","article-title":"Neurodegenerative effect of DAPK1 after cerebral hypoxia-ischemia is associated with its post-transcriptional and signal transduction regulations: a systematic review and meta-analysis","volume":"76","author":"Khan","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2022.101764_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroscience.2018.09.017","article-title":"Proteomic profiling of exosomal proteins for blood-based biomarkers in Parkinson's disease","volume":"392","author":"Kitamura","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2022.101764_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2018.11.002","article-title":"Portrait of blood-derived extracellular vesicles in patients with Parkinson\u2019s disease","volume":"124","author":"Lamontagne-Proulx","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2022.101764_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134866","article-title":"Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients","volume":"723","author":"Leng","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101764_bib52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in Exosome Isolation Techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2022.101764_bib53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","article-title":"Biomarkers for Parkinson\u2019s disease: how good are they?","volume":"36","author":"Li","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.arr.2022.101764_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/657086","article-title":"Exosomes: novel biomarkers for clinical diagnosis","volume":"2015","author":"Lin","year":"2015","journal-title":"Sci. World J."},{"key":"10.1016\/j.arr.2022.101764_bib55","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/srep00954","article-title":"DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease","volume":"2","author":"Lin","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101764_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.11.020","article-title":"Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study","volume":"93","author":"Manna","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2022.101764_bib57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson's disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem"},{"key":"10.1016\/j.arr.2022.101764_bib58","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2022.101764_bib59","first-page":"163","article-title":"Conducting systematic reviews of association (etiology): the Joanna Briggs Institute's approach","volume":"13","author":"Moola","year":"2015","journal-title":"JBI Evid. Implement"},{"key":"10.1016\/j.arr.2022.101764_bib60","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"10.1016\/j.arr.2022.101764_bib61","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/ene.14208","article-title":"A longitudinal study on \u03b1\u2010synuclein in plasma neuronal exosomes as a biomarker for Parkinson\u2019s disease development and progression","volume":"27","author":"Niu","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2022.101764_bib62","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","article-title":"L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma","volume":"18","author":"Norman","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.arr.2022.101764_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.11.021","article-title":"Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases","volume":"61","author":"Ohmichi","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2022.101764_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41531-021-00203-9","article-title":"Alpha-synuclein research: defining strategic moves in the battle against Parkinson\u2019s disease","volume":"7","author":"Oliveira","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2022.101764_bib65","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101764_bib66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.arr.2022.101764_bib67","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7861\/clinmedicine.16-4-371","article-title":"Imaging in Parkinson's disease","volume":"16","author":"Pagano","year":"2016","journal-title":"Clin. Med."},{"key":"10.1016\/j.arr.2022.101764_bib68","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2022.101764_bib69","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1523\/JNEUROSCI.0285-07.2007","article-title":"Aggregated \u03b1-synuclein mediates dopaminergic neurotoxicity in vivo","volume":"27","author":"Periquet","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib70","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.15288","article-title":"Exosomes in Parkinson disease","volume":"157","author":"Pinnell","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2022.101764_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.parkreldis.2019.09.008","article-title":"Neuronal exosomes in saliva of Parkinson's disease patients: a pilot study","volume":"67","author":"Rani","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2022.101764_bib72","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/cells10040791","article-title":"Protein binding partners of dysregulated miRNAs in Parkinson\u2019s disease serum","volume":"10","author":"Ruf","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arr.2022.101764_bib73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12883-018-1072-x","article-title":"Parkinson\u2019s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism","volume":"18","author":"van Rumund","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2022.101764_bib74","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease","volume":"128","author":"Shi","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2022.101764_bib75","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","article-title":"CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease","volume":"12","author":"Shi","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2022.101764_bib76","article-title":"Decreased exosomal acetylcholinesterase activity in the plasma of patients with Parkinson\u2019s disease","volume":"13","author":"Shim","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib77","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2019.05.015","article-title":"Central nervous system-derived exosomal alpha-synuclein in serum may be a biomarker in Parkinson\u2019s disease","volume":"413","author":"Si","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2022.101764_bib78","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.3390\/ijms22052737","article-title":"Different miRNA profiles in plasma derived small and large extracellular vesicles from patients with neurodegenerative diseases","volume":"22","author":"Sproviero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2022.101764_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"Br. Med. J."},{"key":"10.1016\/j.arr.2022.101764_bib80","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/awv346","article-title":"Induction of \u03b1-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies","volume":"139","author":"Stuendl","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.arr.2022.101764_bib81","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.28639","article-title":"\u03b1\u2010Synuclein in plasma\u2010derived extracellular vesicles is a potential biomarker of Parkinson's disease","volume":"36","author":"Stuendl","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2022.101764_bib82","doi-asserted-by":"crossref","first-page":"10733","DOI":"10.1021\/acs.analchem.0c02006","article-title":"Exosome purification and analysis using a facile microfluidic hydrodynamic trapping device","volume":"92","author":"Tayebi","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.arr.2022.101764_bib83","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","article-title":"Extracellular vesicles in neurodegenerative disease -pathogenesis to biomarkers","volume":"12","author":"Thompson","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2022.101764_bib84","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000866","article-title":"Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease","volume":"7","author":"Vacchi","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2022.101764_bib85","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fneur.2020.00595","article-title":"Biofluid markers for prodromal Parkinson's disease: evidence from a catecholaminergic perspective","volume":"11","author":"Vermeiren","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2022.101764_bib86","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1756-5391.2011.01122.x","article-title":"Ethical issues in preparing and publishing systematic reviews","volume":"4","author":"Wager","year":"2011","journal-title":"J. Evid. Based Med."},{"key":"10.1016\/j.arr.2022.101764_bib87","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2022.101764_bib88","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/cns.13277","article-title":"Integrated analysis of exosomal lncRNA and mRNA expression profiles reveals the involvement of lnc\u2010MKRN2\u201342: 1 in the pathogenesis of Parkinson's disease","volume":"26","author":"Wang","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2022.101764_bib89","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-017-0492-y","article-title":"Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers","volume":"5","author":"Wang","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2022.101764_bib90","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2019.06.021","article-title":"Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease","volume":"45","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2022.101764_bib91","doi-asserted-by":"crossref","first-page":"20360","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.arr.2022.101764_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101694","article-title":"Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents","volume":"183","author":"Xia","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2022.101764_bib93","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41419-019-1404-9","article-title":"Microglia as modulators of exosomal alpha-synuclein transmission","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2022.101764_bib94","article-title":"Alpha-synuclein in Parkinson\u2019s disease: from pathogenetic dysfunction to potential clinical application","volume":"2016","author":"Xu","year":"2016","journal-title":"Park. Dis."},{"key":"10.1016\/j.arr.2022.101764_bib95","first-page":"5278","article-title":"Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson\u2019s disease","volume":"22","author":"Yao","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.arr.2022.101764_bib96","doi-asserted-by":"crossref","first-page":"15783","DOI":"10.1038\/s41598-021-95062-y","article-title":"Higher senescence associated secretory phenotype and lower defense mediator in urinary extracellular vesicles of elders with and without Parkinson disease","volume":"11","author":"Yeh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101764_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202100287","article-title":"The chaperone Clusterin in neurodegeneration\u2212 friend or foe?","volume":"44","author":"Yuste\u2010Checa","year":"2022","journal-title":"Bioessays"},{"key":"10.1016\/j.arr.2022.101764_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.24113","article-title":"A novel cell\u2010cell communication mechanism in the nervous system: exosomes","volume":"96","author":"Zhang","year":"2018","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.arr.2022.101764_bib99","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fneur.2018.00809","article-title":"Tau pathology in Parkinson's disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2022.101764_bib100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.redox.2017.11.001","article-title":"\u03b1-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice","volume":"14","author":"Zhang","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.arr.2022.101764_bib101","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","article-title":"Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2022.101764_bib102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2021.06.033","article-title":"Investigation of \u03b1-synuclein species in plasma exosomes and the oligomeric and phosphorylated \u03b1-synuclein as potential peripheral biomarker of Parkinson\u2019s disease","volume":"469","author":"Zheng","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2022.101764_bib103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/cns.12493","article-title":"Position emission tomography\/single-photon emission tomography neuroimaging for detection of premotor Parkinson's disease","volume":"22","author":"Zou","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2022.101764_bib104","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s13311-020-00842-5","article-title":"Long noncoding RNA POU3F3 and \u03b1-synuclein in plasma L1CAM exosomes combined with \u03b2-glucocerebrosidase activity: potential predictors of Parkinson\u2019s disease","volume":"17","author":"Zou","year":"2020","journal-title":"Neurotherapeutics"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722002069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722002069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:57:33Z","timestamp":1778522253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163722002069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":104,"alternative-id":["S1568163722002069"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2022.101764","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of exosomal biomarkers and its optimal isolation and detection method for the diagnosis of Parkinson's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2022.101764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101764"}}